483
Pillar5 Pharma Inc.Pillar5 Pharma Inc. – FDA 483, Dec 15, 2023
Record Details
Pillar5 Pharma Inc., a manufacturer of sterile OTC drug products, received a Form 483 citing significant deficiencies. Observations included inadequate validation of aseptic processes, failures in investigating microbial excursions and consumer complaints, and deficiencies in their supplier qualification program for container/closure systems. These issues indicate a lack of robust quality control and process validation for sterile drug manufacturing.
View Company Profile
ID · 49d12328-3ebf-4ca3-ade2-5b08703919fb
Other documents for Pillar5 Pharma Inc.
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.